Validated QPS Assays
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno-bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
Search For An Assay Here
Didanosine (ddI)
Stavudine (d4T)
Zidovudine (AZT)
Stavudine (d4T)
Zidovudine (AZT)
Matrix: | Human Plasma |
Assay Range: | 5 - 3,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Digoxin
Matrix: | Human Plasma |
Assay Range: | 0.1 - 30 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Diphenhydramine
Matrix: | Human Plasma |
Assay Range: | 0.2 - 200 ng/mL |
Sample Volume: | 0.03 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Respiratory |
Classification: | Drug Assays |
Dipyridamole in presence of Acetyl Salicylic Acid
Matrix: | Human Plasma |
Assay Range: | 10 - 5,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Docetaxel
Paclitaxel (Taxol)
Paclitaxel (Taxol)
Matrix: | Human Plasma |
Assay Range: | 2 - 1,000 ng/mL 5 - 2,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Docetaxel
Paclitaxel (Taxol)
Paclitaxel (Taxol)
Matrix: | Human Plasma |
Assay Range: | 2 - 1,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Docetaxel
Paclitaxel (Taxol)
Paclitaxel (Taxol)
Matrix: | Human Serum |
Assay Range: | 2 - 2,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | N/A |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Dolutegravir (DTG)
Matrix: | Human Plasma |
Assay Range: | 20 - 20,000 ng/mL |
Sample Volume: | 0.025 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Dolutegravir (DTG)
Matrix: | Human Plasma |
Assay Range: | 20 - 12,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Dolutegravir (DTG) in presence of Tenofovir (TFV), Lamivudine (3TC), Abacavir (ABC), Emtricitabine
Matrix: | Human Plasma |
Assay Range: | 20 - 10,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Domperidone
Matrix: | Human Plasma |
Assay Range: | 0.3 - 50 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Gastrointestinal |
Classification: | Drug Assays |
Donepezil
Matrix: | Human Plasma |
Assay Range: | 0.1 - 20 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Dementia and Alzheimer's Disease |
Classification: | Drug Assays |
Donepezil
Matrix: | Human Plasma |
Assay Range: | 0.2 to 200 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | K2 EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Dementia and Alzheimer's Disease |
Classification: | Drug Assays |
Donepezil
Matrix: | Human Plasma |
Assay Range: | 0.2 - 50 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Dementia and Alzheimer's Disease |
Classification: | Drug Assays |
Donepezil
Matrix: | Human Plasma |
Assay Range: | 0.2 - 40 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Dementia and Alzheimer's Disease |
Classification: | Drug Assays |
Donepezil
Matrix: | Human Plasma |
Assay Range: | 0.2 - 50 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Dementia and Alzheimer's Disease |
Classification: | Drug Assays |
Doxazosin
Matrix: | Human Plasma |
Assay Range: | 0.2 - 20 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Doxazosin
Matrix: | Human Plasma |
Assay Range: | 0.1 - 30 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Doxepin
Matrix: | Human Plasma |
Assay Range: | 0.1 - 60 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antidepressant |
Classification: | Drug Assays |
Doxepin Nor-doxepin
Matrix: | Human Plasma |
Assay Range: | 0.3 - 180 ng/mL 0.3 - 60 ng/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC-MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antidepressant |
Classification: | Drug Assays |
Doxepin
Nor-doxepin
Nor-doxepin
Matrix: | Human Plasma |
Assay Range: | 0.1 - 120 ng/mL 0.1 - 60 ng/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antidepressant |
Classification: | Drug Assays |
Doxycycline
Matrix: | Human Plasma |
Assay Range: | 10 - 1,500 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Doxycycline
Matrix: | Human Plasma |
Assay Range: | 10 - 6,000 ng/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Doxycycline
Matrix: | Human Plasma |
Assay Range: | 20 - 2,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Doxycycline
Matrix: | Human Plasma |
Assay Range: | 25.0 - 5,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Links to Relevant Documents
Testimonials
Thanks for the good news, I’m happy to see that within less than a month you will have developed and validated the assay. Good Job!
QPS CLIENT